Cargando…
Danggui Sini decoction treatment of refractory allergic cutaneous vasculitis: A case report
BACKGROUND: Allergic cutaneous vasculitis (ACV) is a difficult disease to treat. At present, there is no effective treatment for this condition. Traditionally, immunosuppressants and hormones have been primarily used in its management, but the treatment effect is suboptimal, and it has several side...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724523/ https://www.ncbi.nlm.nih.gov/pubmed/36483805 http://dx.doi.org/10.12998/wjcc.v10.i33.12422 |
_version_ | 1784844436258160640 |
---|---|
author | Chen, Xi-Ya Wu, Zhi-Ming Wang, Rui Cao, Yu-Hong Tao, Yong-Lian |
author_facet | Chen, Xi-Ya Wu, Zhi-Ming Wang, Rui Cao, Yu-Hong Tao, Yong-Lian |
author_sort | Chen, Xi-Ya |
collection | PubMed |
description | BACKGROUND: Allergic cutaneous vasculitis (ACV) is a difficult disease to treat. At present, there is no effective treatment for this condition. Traditionally, immunosuppressants and hormones have been primarily used in its management, but the treatment effect is suboptimal, and it has several side effects. CASE SUMMARY: We present the case of a 19-year-old woman who presented at our hospital with a four-year history of symmetric skin lesions mainly affecting her lower extremities. She had previously undergone treatment with prednisolone acetate, cetirizine hydrochloride, and loratadine tablets but had not experienced any relief in her condition. Thereafter, she was treated with oral traditional Chinese medicine. Her skin damage gradually improved within two months of treatment initiation. After six months, the skin ulcers had completely subsided. No evidence of skin ulcer recurrence was observed during the subsequent follow-up. This report presents the first case of a female patient who received oral Danggui Sini decoction for the treatment of ACV. CONCLUSION: Danggui Sini decoction may be a promising oral treatment for ACV patients. |
format | Online Article Text |
id | pubmed-9724523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-97245232022-12-07 Danggui Sini decoction treatment of refractory allergic cutaneous vasculitis: A case report Chen, Xi-Ya Wu, Zhi-Ming Wang, Rui Cao, Yu-Hong Tao, Yong-Lian World J Clin Cases Case Report BACKGROUND: Allergic cutaneous vasculitis (ACV) is a difficult disease to treat. At present, there is no effective treatment for this condition. Traditionally, immunosuppressants and hormones have been primarily used in its management, but the treatment effect is suboptimal, and it has several side effects. CASE SUMMARY: We present the case of a 19-year-old woman who presented at our hospital with a four-year history of symmetric skin lesions mainly affecting her lower extremities. She had previously undergone treatment with prednisolone acetate, cetirizine hydrochloride, and loratadine tablets but had not experienced any relief in her condition. Thereafter, she was treated with oral traditional Chinese medicine. Her skin damage gradually improved within two months of treatment initiation. After six months, the skin ulcers had completely subsided. No evidence of skin ulcer recurrence was observed during the subsequent follow-up. This report presents the first case of a female patient who received oral Danggui Sini decoction for the treatment of ACV. CONCLUSION: Danggui Sini decoction may be a promising oral treatment for ACV patients. Baishideng Publishing Group Inc 2022-11-26 2022-11-26 /pmc/articles/PMC9724523/ /pubmed/36483805 http://dx.doi.org/10.12998/wjcc.v10.i33.12422 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Case Report Chen, Xi-Ya Wu, Zhi-Ming Wang, Rui Cao, Yu-Hong Tao, Yong-Lian Danggui Sini decoction treatment of refractory allergic cutaneous vasculitis: A case report |
title | Danggui Sini decoction treatment of refractory allergic cutaneous vasculitis: A case report |
title_full | Danggui Sini decoction treatment of refractory allergic cutaneous vasculitis: A case report |
title_fullStr | Danggui Sini decoction treatment of refractory allergic cutaneous vasculitis: A case report |
title_full_unstemmed | Danggui Sini decoction treatment of refractory allergic cutaneous vasculitis: A case report |
title_short | Danggui Sini decoction treatment of refractory allergic cutaneous vasculitis: A case report |
title_sort | danggui sini decoction treatment of refractory allergic cutaneous vasculitis: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724523/ https://www.ncbi.nlm.nih.gov/pubmed/36483805 http://dx.doi.org/10.12998/wjcc.v10.i33.12422 |
work_keys_str_mv | AT chenxiya dangguisinidecoctiontreatmentofrefractoryallergiccutaneousvasculitisacasereport AT wuzhiming dangguisinidecoctiontreatmentofrefractoryallergiccutaneousvasculitisacasereport AT wangrui dangguisinidecoctiontreatmentofrefractoryallergiccutaneousvasculitisacasereport AT caoyuhong dangguisinidecoctiontreatmentofrefractoryallergiccutaneousvasculitisacasereport AT taoyonglian dangguisinidecoctiontreatmentofrefractoryallergiccutaneousvasculitisacasereport |